- PR Newswire•2 days ago
BOULDER, Colo., April 27, 2017 /PRNewswire/ -- Array BioPharma Inc. (ARRY) today announced that Shalini Sharp, Chief Financial Officer and Executive Vice President of Ultragenyx Pharmaceutical Inc., joined the company's Board of Directors, effective April 27, 2017. Ms. Sharp has served as Chief Financial Officer of Ultragenyx, a biopharmaceutical company focused on rare diseases, since 2012, where she is responsible for leading the corporate finance, strategy, and information technology functions and is a member of the company's executive leadership team. Ms. Sharp brings nearly 20 years of experience in the life sciences industry.
- TheStreet.com•9 days ago
Here's how to potentially rake in some fat profits off a number of hot breakout setups.
- Accesswire•12 days ago
NEW YORK, NY / ACCESSWIRE / April 17, 2017 / The Biotech Industry has continued to provide solid gains for investors in 2017, despite all the negative attention the industry has received due to drug pricing ...
ARRY : Summary for Array BioPharma Inc. - Yahoo Finance
Array BioPharma Inc. (ARRY)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
|Bid||7.95 x 300|
|Ask||9.26 x 300|
|Day's Range||8.50 - 8.80|
|52 Week Range||2.70 - 13.40|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-13.06|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|